Search results
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 46 minutes agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 4 hours agoNovavax will receive $500 million in upfront payments as well as a further $700 million if all...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 2 hours agoNovavax (NVAX 44.26%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 7 hours agoNovavax's Covid-19 vaccine is authorized in select geographies under trade names Novavax Covid-19
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 19 hours agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Company News For May 13, 2024
Zacks via Yahoo Finance· 5 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 17 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
